Status:
UNKNOWN
Sources of COmplement in Meningococcal and Pertussis Serum Bactericidal Antibody Assays
Lead Sponsor:
St George's, University of London
Conditions:
Pertussis
Meningococcal Disease
Eligibility:
FEMALE
16+ years
Brief Summary
This study is designed to allow cord blood sample collection from the cords of babies born in three gestational age windows: ≥37 gestational weeks, 32-36+6 gestational weeks and less than 32 gestation...
Detailed Description
Newborn infants, particularly those who are born preterm, are vulnerable to infection because of their immature immune systems. Invasive meningococcal disease (IMD) and pertussis both represent signif...
Eligibility Criteria
Inclusion
- Pregnant and planning to deliver at St George's University Hospitals NHS Foundation Trust
Exclusion
- Aged less than 16 years
- Known complement deficiency
Key Trial Info
Start Date :
October 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 21 2021
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04023929
Start Date
October 28 2020
End Date
September 21 2021
Last Update
January 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St George's, University of London
London, United Kingdom, SW17 0RE